Skip to main content
. 2015 Jun 1;8(6):6095–6106.

Figure 7.

Figure 7

The comparison between DNMT1 immunoexpression in our study and PCNA immunoexpression by M Sawada and colleague [22]. The discordant of expression after WHO grade III (vertical line) postulates the possibility of DNMT1 aberrant expression in astrocytic tumour especially in high grade tumour.